Literature DB >> 29935845

Primary Resistance to Afatinib in a Patient with Lung Adenocarcinoma Harboring Uncommon EGFR Mutations: S768I and V769L.

Julie Niogret1, Bruno Coudert1, Romain Boidot2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29935845     DOI： 10.1016/j.jtho.2018.02.004

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

1.  Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer.

Authors:  Adam J Schoenfeld; Joseph M Chan; Daisuke Kubota; Hiroki Sato; Hira Rizvi; Yahya Daneshbod; Jason C Chang; Paul K Paik; Michael Offin; Maria E Arcila; Monika A Davare; Ujwal Shinde; Dana Pe'er; Natasha Rekhtman; Mark G Kris; Romel Somwar; Gregory J Riely; Marc Ladanyi; Helena A Yu
Journal:  Clin Cancer Res       Date:  2020-01-07       Impact factor: 12.531

2.  Cryptotanshinone Suppresses Non-Small Cell Lung Cancer via microRNA-146a-5p/EGFR Axis.

Authors:  Pengfei Qi; Yanli Li; Xiaomin Liu; Fatemeh A Jafari; Xinju Zhang; Qiangling Sun; Zhongliang Ma
Journal:  Int J Biol Sci       Date:  2019-04-22       Impact factor: 6.580

3.  Is There a Role for Large Exome Sequencing in the Management of Metastatic Non-Small Cell Lung Cancer: A Brief Report of Real Life.

Authors:  Lorraine Dalens; Julie Niogret; Courèche Guillaume Kaderbhai; Romain Boidot
Journal:  Front Oncol       Date:  2022-03-07       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.